{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard acute treatment for suspected inflammatory demyelinating relapse To reduce inflammation and minimize residual neurological deficit\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection during high-dose steroid therapy Symptomatic relief for presenting heartburn symptoms\n\n*   **Treatment:** Long-term Immunotherapy (e.g., Rituximab, Eculizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Specific agent choice depends on confirmation of AQP4/MOG antibody status Requires completion of acute infection screening\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard acute treatment for suspected inflammatory demyelinating relapse\", \"To reduce inflammation and minimize residual neurological deficit\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection during high-dose steroid therapy\", \"Symptomatic relief for presenting heartburn symptoms\"]}, {\"treatment\": \"Long-term Immunotherapy (e.g., Rituximab, Eculizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Specific agent choice depends on confirmation of AQP4/MOG antibody status\", \"Requires completion of acute infection screening\"]}]"
}